{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:26:07Z","timestamp":1788564367314,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-022-04241-4","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T19:36:36Z","timestamp":1661369796000},"page":"1937-1944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chemoradiation vs. local excision in the management of early squamous cell carcinoma of the anus: a systematic review"],"prefix":"10.1007","volume":"37","author":[{"given":"Giuseppe","family":"Portale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Parotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cavallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"4241_CR1","first-page":"401","volume":"71","author":"RP Van der Zee","year":"2013","unstructured":"Van der Zee RP, Richel O, de Vries HJ, Prins JM (2013) The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med 71:401\u2013411","journal-title":"Neth J Med"},{"key":"4241_CR2","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","volume":"31","author":"RA Nelson","year":"2013","unstructured":"Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL (2013) Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 31:1569\u20131575","journal-title":"J Clin Oncol"},{"key":"4241_CR3","unstructured":"Surveillance, Epidemiology, and End Results Program. Stat fact sheets: Anal Cancer. Available online: http:\/\/seer.cancer.gov\/statfacts\/html\/anus.html. Accessed 25 Jun 2022"},{"key":"4241_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon rectum 17:354\u2013356","journal-title":"Dis Colon rectum"},{"key":"4241_CR5","unstructured":"Benson AB, Venook AP, Al-Hawari MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I et al (2022) NCCN Clinical Practice Guidelines in Oncology: Anal carcinoma, Version 1"},{"key":"4241_CR6","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:iii10\u201320","DOI":"10.1093\/annonc\/mdu159"},{"key":"4241_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/DCR.0000000000001114","volume":"61","author":"DB Stewart","year":"2018","unstructured":"Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR (2018) The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for anal squamous cell cancers. Dis Colon Rectum 61:755\u2013774","journal-title":"Dis Colon Rectum"},{"key":"4241_CR8","doi-asserted-by":"crossref","unstructured":"Arnott S, Cunningham J, Gallagher J (1996) UK Coordinating Committee on Cancer Research Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. Lancet 348:1049\u20131054","DOI":"10.1016\/S0140-6736(96)03409-5"},{"key":"4241_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jital M, Ledermann J (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 102:1123\u20131128","journal-title":"Br J Cancer"},{"key":"4241_CR10","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and treatment of Cancer Radiotherapy Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040\u20132049","journal-title":"J Clin Oncol"},{"key":"4241_CR11","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L et al (1996) Role of the mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527\u20132539","journal-title":"J Clin Oncol"},{"key":"4241_CR12","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914\u20131921","journal-title":"JAMA"},{"key":"4241_CR13","doi-asserted-by":"crossref","unstructured":"Gunderson LL, Winter KA, Ajani JA, Lemanski C, Francois E, Giovannini M, CvitKovic F, Mirabel X, Bouch\u00e8 O, Luporsi E et al (2012) Long-term update of US GI intergroup RTOG 98\u201311 phase II trial for anal carcinoma: survival, relapse and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 30\u20134344\u20134351","DOI":"10.1200\/JCO.2012.43.8085"},{"key":"4241_CR14","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, Gerard JP et al (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNI-CANCER ACCORD 03 trial. J Clin Oncol 30:1941\u20131948","journal-title":"J Clin Oncol"},{"key":"4241_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomized, phase 3 open-label 2 x 2 factorial trial. Lancet Oncol 14:516\u2013524","journal-title":"Lancet Oncol"},{"key":"4241_CR16","doi-asserted-by":"crossref","unstructured":"Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease., treatment, and outcomes. Cancer 85:1686\u20131693","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1686::AID-CNCR7>3.0.CO;2-7"},{"key":"4241_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0147-0272(80)80015-8","volume":"4","author":"MW Stearns","year":"1980","unstructured":"Stearns MW, Urmacher C, Sternberg SS, Woodruff J, Attiyeh F (1980) Cancer of the anal canal. Curr Probl Cancer 4:1\u201344","journal-title":"Curr Probl Cancer"},{"key":"4241_CR18","doi-asserted-by":"crossref","unstructured":"Boman BM, Moertel CG, O\u2019Connell MJ, Scott M, Weiland LH, Beart RW, Gunderson LL, Spencer RJ (1984) Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 54:114\u2013125","DOI":"10.1002\/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P"},{"key":"4241_CR19","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","DOI":"10.1001\/jama.283.15.2008"},{"key":"4241_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 73:712\u2013716","journal-title":"ANZ J Surg"},{"key":"4241_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamasurg.2017.3151","volume":"153","author":"CY Chai","year":"2018","unstructured":"Chai CY, Tran Cao HS, Awad S, Massarweh NN (2018) Management of stage I squamous cell carcinoma of the anal canal. JAMA Surg 153:209\u2013215","journal-title":"JAMA Surg"},{"key":"4241_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/COC.0000000000000339","volume":"41","author":"AA Desmukh","year":"2018","unstructured":"Desmukh AA, Zhao H, Das P, Chiao EY, Nancy You YQ, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB (2018) Clinical and economic evaluation of treatment strategies for T1N0 anal canal cancer. Am J Clin Oncol 41:626\u2013631","journal-title":"Am J Clin Oncol"},{"key":"4241_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21037\/jgo.2018.12.12","volume":"10","author":"S Chakrabarti","year":"2019","unstructured":"Chakrabarti S, Jin Z, Huffman BM, Yadav S, Graham RP, Lam-Himlin DM, Lightner AL, Hallemeier CL, Mahipal A (2019) Local excision for patients with stage I anal canal squamous cell carcinoma can be curative. J Gastrointest Oncol 10:171\u2013178","journal-title":"J Gastrointest Oncol"},{"key":"4241_CR24","doi-asserted-by":"crossref","unstructured":"Gao X, Goffredo P, Kahl AR, Charlton ME, Weigel RJ (2020) Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: a population-based analysis. Eur J Surg Oncol pii: S0748\u20137983(20)30150\u20135","DOI":"10.1016\/j.ejso.2020.03.003"},{"key":"4241_CR25","doi-asserted-by":"crossref","unstructured":"Kang YJ, Smith M, Canfell K (2018) Anal cancer in high-income countries: increasing burden of disease. PloS One 13(10):e0205105","DOI":"10.1371\/journal.pone.0205105"},{"key":"4241_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/cid\/ciz408","volume":"70","author":"EA Stier","year":"2020","unstructured":"Stier EA, Lensing SY, Darragh TM, Deshmukh AA, Einstein MH, Palefsky JM, Jay N, Berry-Lawhorn JM, Wilkin T, Wiley DJ et al (2020) Prevalence of risk factors for anal high-grade squamous intraepithelial lesions in women living with human immunodeficency virus. Clin Infect Dis 70:1701\u20131707","journal-title":"Clin Infect Dis"},{"key":"4241_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4240\/wjgs.v8.i1.41","volume":"8","author":"IL Leeds","year":"2016","unstructured":"Leeds IL, Fang SH (2016) Anal cancer and intraepithelial neoplasia screening: a review. World J Gastrointest Surg 8:41\u201351","journal-title":"World J Gastrointest Surg"},{"key":"4241_CR28","unstructured":"Clinicaltrials.gov. Topical or ablativetreatment in preventing anal cancer in patients with HGIV and high-grade squamous intraepithelial lesions (ANCHOR) NCT02135419 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02135419. Accessed 25 Jun 2022"},{"key":"4241_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/DCR.0b013e3182a226bd","volume":"56","author":"J Dojen","year":"2013","unstructured":"Dojen J, Benezery K, Follana P, Ortholan C, Gerard JP, Hannoun-Levi JM, Gal J, Francois E (2013) Predictive factors for early and late toxicities in anal cnacer treated by radiotherapy in combination with or without chemotherapy. Dis Colon Rectum 56:1125\u20131233","journal-title":"Dis Colon Rectum"},{"key":"4241_CR30","doi-asserted-by":"crossref","unstructured":"Bentzen AG, Guren MG, Vonen B, Wanderas EH, Frykholm G, Wilsgaard T, Dahl O, Balteskard L (2013) Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort","DOI":"10.1016\/j.radonc.2013.05.037"},{"key":"4241_CR31","doi-asserted-by":"crossref","unstructured":"Devisetty K, Mell LK, Salama JK, Schomas DA Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ (2009) A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 93:298\u2013301","DOI":"10.1016\/j.radonc.2009.07.006"},{"key":"4241_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.soc.2016.07.004","volume":"26","author":"EB Ludmir","year":"2017","unstructured":"Ludmir EB, Kachnic LA, Czito BG (2017) Evolution and management of treatment-related toxicity in anal cancer. Surg Oncol Clin 26:91\u2013113","journal-title":"Surg Oncol Clin"},{"key":"4241_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamasurg.2018.0394","volume":"153","author":"AG Renehan","year":"2018","unstructured":"Renehan AG, Muirhead R, Sebag-Montefiore D (2018) Limitations of the National Cancer Data Base to evaluate early-stage anal cancer treatment outcomes. JAMA Surg 153:691","journal-title":"JAMA Surg"},{"key":"4241_CR34","unstructured":"National Cancer Data Base (NCDB). Available at: http:\/\/www.facs.org\/cancer\/ncdb\/. Accessed 25 Jun 2022"},{"key":"4241_CR35","unstructured":"Surveillance Epidemiology and End Results (SEER). Available at: http:\/\/seer.cancer.gov\/. Accessed 25 Jun 2022"},{"key":"4241_CR36","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1245\/s10434-014-3516-x","volume":"21","author":"H In","year":"2014","unstructured":"In H, Bilimoria KY, Stewart AK, Wroblewski KE, Posner MC, Talamonti MS, Winchester DP (2014) Cancer recurrence: an important but missing variable in National Cancer Registries. Ann Surg Oncol 21:1520\u20131529","journal-title":"Ann Surg Oncol"},{"key":"4241_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00384-021-03846-5","volume":"36","author":"G Talwar","year":"2021","unstructured":"Talwar G, Daniel R, McKechnie T, Levine O, Eskicioglu C (2021) Radiotherapy alone versus chemoradiotherapy for stage I anal squamous cell carcinoma: a systematic review and meta-analysis. Int J Colorectal Dis 36:1111\u20131122","journal-title":"Int J Colorectal Dis"},{"key":"4241_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.clcc.2019.06.003","volume":"18","author":"G Eng","year":"2019","unstructured":"Eng G, J\u00e1come AA, Das P, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Wolff RA, Qiao W, Xing Y, Sethi S, Ohinata A, Crane CH (2019) Phase II study of capecitabine\/oxaliplatin with concurrent radiotherapy in locally-advanced squamous cell carcinoma of the anal canal. Clin Colorectal Cancer 18:301\u2013306","journal-title":"Clin Colorectal Cancer"},{"key":"4241_CR39","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1002\/cncr.31721","volume":"124","author":"JK Elson","year":"2018","unstructured":"Elson JK, Kachnic LA, Kharofa J (2018) Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus. Cancer 124:4383\u20134392","journal-title":"Cancer"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-022-04241-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-022-04241-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T12:09:32Z","timestamp":1662034172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-022-04241-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["4241"],"URL":"https:\/\/doi.org\/10.1007\/s00384-022-04241-4","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"15 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}